Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangzhou Lin

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Elife|September 13, 2024
Engineering PEG10assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccinationRuijing Tang, Luobin Guo, Tingyu Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 31, 2025
Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse ModelsZhixiong Cai, Zhenli Li, Wenting Zhong, et al.
EMBO Molecular Medicine|April 17, 2026
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunityRuijing Tang, Honghao Ye, Geng Chen, et al.
Cell Reports. Medicine|April 21, 2026
Spleen-targeted neoantigen mRNA vaccine induces ISG15<sup>+</sup> CD8<sup>+</sup> T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinomaXinyi Lin, Geng Chen, Ruijing Tang, et al.
Journal for Immunotherapy of Cancer|December 18, 2024
Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8<sup>+</sup>CD69<sup>+</sup> T cellsShichuan Tang, Ruijing Tang, Geng Chen, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Elife|September 13, 2024
Engineering PEG10assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccinationRuijing Tang, Luobin Guo, Tingyu Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 31, 2025
Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse ModelsZhixiong Cai, Zhenli Li, Wenting Zhong, et al.
EMBO Molecular Medicine|April 17, 2026
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunityRuijing Tang, Honghao Ye, Geng Chen, et al.
Cell Reports. Medicine|April 21, 2026
Spleen-targeted neoantigen mRNA vaccine induces ISG15<sup>+</sup> CD8<sup>+</sup> T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinomaXinyi Lin, Geng Chen, Ruijing Tang, et al.
Journal for Immunotherapy of Cancer|December 18, 2024
Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8<sup>+</sup>CD69<sup>+</sup> T cellsShichuan Tang, Ruijing Tang, Geng Chen, et al.
Pageof 2